Sugammadex analog water soluble BCD polymer for peptide complexes
In this work, an integrated biophysical and biological study is presented describing both the structural and biological features of the
A forum for researchers, students and applicants in the field of cyclodextrin technology
In this work, an integrated biophysical and biological study is presented describing both the structural and biological features of the
The scope of this review is to provide a comprehensive overview of the current synthetic methodologies for both mono- and
The comprehensive physicochemical characterization and cyclodextrin complexation of four tyrosine kinase inhibitors — erlotinib, gefitinib, vandetanib, and lapatinib — were
This review elaborates the recent developments in the cationic cyclodextrin-mediated delivery of drugs and nucleic acids. Cationic cyclodextrin-based delivery systems
Glutathione-responsive cyclodextrin nanosponges (CDNSs) exploit intracellular redox gradients via disulfide bond cleavage, enabling selective drug release in cancerous and inflammatory
Annexin A1 (AnxA1) was identified as an endogenous regulator of inflammation in dengue. Treatment with the AnxA1 peptidomimetic, Ac2-26, improved
The Bubble-Driven Drug Delivery System (BDDS, a new name for effervescent formulations) was optimized through the screening of effervescent formulations
This study integrates molecular modeling and meta-analysis to evaluate the pharmacokinetic performance and molecular stability of various cyclodextrin-drug systems. A
In this study, nanogels were developed using thiolated hyaluronic acid (HASH) and vinyl sulfonated β-cyclodextrin (CDVS) via a water-in-oil emulsion
Cancer is a complex disease characterized by systemic dysfunction, necessitating a balance between therapeutic efficacy and safety. Immunotherapy is a